These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
409 related items for PubMed ID: 17949552
1. Intracellular cytokine patterns in Behçet's disease in comparison to ankylosing spondylitis--influence of treatment with interferon-alpha2a. Amberger M, Groll S, Günaydin I, Deuter C, Vonthein R, Kötter I. Clin Exp Rheumatol; 2007; 25(4 Suppl 45):S52-7. PubMed ID: 17949552 [Abstract] [Full Text] [Related]
3. Increased frequencies of interleukin-2- and interferon-gamma-producing T cells in patients with active Behçet's disease. Sugi-Ikai N, Nakazawa M, Nakamura S, Ohno S, Minami M. Invest Ophthalmol Vis Sci; 1998 May; 39(6):996-1004. PubMed ID: 9579479 [Abstract] [Full Text] [Related]
4. Down-regulation of the nonspecific and antigen-specific T cell cytokine response in ankylosing spondylitis during treatment with infliximab. Zou J, Rudwaleit M, Brandt J, Thiel A, Braun J, Sieper J. Arthritis Rheum; 2003 Mar; 48(3):780-90. PubMed ID: 12632433 [Abstract] [Full Text] [Related]
5. Behçet's disease: immunological relevance with arthritis of ankylosing spondylitis. Aktas Cetin E, Cosan F, Kucuksezer UC, Bilgic S, Cagatay Y, Gul A, Deniz G. Rheumatol Int; 2013 Mar; 33(3):733-41. PubMed ID: 22576660 [Abstract] [Full Text] [Related]
6. Cytokines, cytokine antagonists and soluble adhesion molecules in patients with ocular Behçet's disease treated with human recombinant interferon-alpha2a. Results of an open study and review of the literature. Kötter I, Koch S, Vonthein R, Rückwaldt U, Amberger M, Günaydin I, Zierhut M, Stübiger N. Clin Exp Rheumatol; 2005 Mar; 23(4 Suppl 38):S20-6. PubMed ID: 16273760 [Abstract] [Full Text] [Related]
7. Down-regulation of IFN-gamma-producing CD56+ T cells after combined low-dose cyclosporine/prednisone treatment in patients with Behçet's uveitis. Ahn JK, Seo JM, Yu J, Oh FS, Chung H, Yu HG. Invest Ophthalmol Vis Sci; 2005 Jul; 46(7):2458-64. PubMed ID: 15980236 [Abstract] [Full Text] [Related]
8. Analysis of Th1 and Th2 cytokines expressing CD4+ and CD8+ T cells in rheumatoid arthritis by flow cytometry. Berner B, Akça D, Jung T, Muller GA, Reuss-Borst MA. J Rheumatol; 2000 May; 27(5):1128-35. PubMed ID: 10813277 [Abstract] [Full Text] [Related]
9. The expression of transmembrane and soluble CXCL16 and the relation with interferon-alpha secretion in patients with Behçet's disease. Yilmaz S, Cinar M, Pekel A, Simsek I, Musabak U, Erdem H, Pay S. Clin Exp Rheumatol; 2013 May; 31(3 Suppl 77):84-7. PubMed ID: 24064021 [Abstract] [Full Text] [Related]
11. Pronounced interferon-alpha production from plasmacytoid dendritic cells in patients with Behçet's disease following CpG D ODN stimulation. Pay S, Pekel A, Simsek I, Musabak U, Erdem H, Dinc A, Kose O. Clin Exp Rheumatol; 2009 May; 27(2 Suppl 53):S37-42. PubMed ID: 19796531 [Abstract] [Full Text] [Related]
12. Th17-Inducing Conditions Lead to in vitro Activation of Both Th17 and Th1 Responses in Behcet's Disease. Deniz R, Tulunay-Virlan A, Ture Ozdemir F, Unal AU, Ozen G, Alibaz-Oner F, Aydin-Tatli I, Mumcu G, Ergun T, Direskeneli H. Immunol Invest; 2017 Jul; 46(5):518-525. PubMed ID: 28414558 [Abstract] [Full Text] [Related]
13. Gammadelta T cells in Behçet's disease (BD) and recurrent aphthous stomatitis (RAS). Freysdottir J, Lau S, Fortune F. Clin Exp Immunol; 1999 Dec; 118(3):451-7. PubMed ID: 10594567 [Abstract] [Full Text] [Related]
14. Abnormal expression of chemokine receptors in Behçet's disease: relationship to intracellular Th1/Th2 cytokines and to clinical manifestations. Houman H, Hamzaoui A, Ben Ghorbal I, Khanfir M, Feki M, Hamzaoui K. J Autoimmun; 2004 Nov; 23(3):267-73. PubMed ID: 15501397 [Abstract] [Full Text] [Related]
15. IFN-alpha blocks IL-17 production by peripheral blood mononuclear cells in Behcet's disease. Liu X, Yang P, Wang C, Li F, Kijlstra A. Rheumatology (Oxford); 2011 Feb; 50(2):293-8. PubMed ID: 21059671 [Abstract] [Full Text] [Related]
16. TNF-alpha gene 1031 T/C polymorphism in Turkish patients with Behçet's disease. Akman A, Sallakci N, Coskun M, Bacanli A, Yavuzer U, Alpsoy E, Yegin O. Br J Dermatol; 2006 Aug; 155(2):350-6. PubMed ID: 16882174 [Abstract] [Full Text] [Related]
17. Anti-interferon alpha antibodies and autoantibodies in patients with Behçet's disease uveitis treated with recombinant human interferon alpha-2a. Aydinoglu-Candan Ö, Araz-Erşan B, Gul A, Badur S, Tugal-Tutkun I. Graefes Arch Clin Exp Ophthalmol; 2015 Mar; 253(3):457-65. PubMed ID: 25500983 [Abstract] [Full Text] [Related]
18. Relation of HLA-B27, tumor necrosis factor-α promoter gene polymorphisms, and T cell cytokine production in ankylosing spondylitis -- a comprehensive genotype-phenotype analysis from an observational cohort. Poddubnyy DA, Märker-Hermann E, Kaluza-Schilling W, Zeidler H, Braun J, Listing J, Sieper J, Rudwaleit M. J Rheumatol; 2011 Nov; 38(11):2436-41. PubMed ID: 21885496 [Abstract] [Full Text] [Related]
19. [Effect of tripterygium glycosides on serum interleukin-1beta, interleukin-2, tumor necrosis factor alpha, and interferon-gamma levels in patients with Behcet's disease]. Song Q, Lu JZ, Li J. Zhongguo Zhong Xi Yi Jie He Za Zhi; 2010 Jun; 30(6):598-600. PubMed ID: 20815274 [Abstract] [Full Text] [Related]
20. Excessive CD4+ T cells co-expressing interleukin-17 and interferon-γ in patients with Behçet's disease. Shimizu J, Takai K, Fujiwara N, Arimitsu N, Ueda Y, Wakisaka S, Yoshikawa H, Kaneko F, Suzuki T, Suzuki N. Clin Exp Immunol; 2012 Apr; 168(1):68-74. PubMed ID: 22385240 [Abstract] [Full Text] [Related] Page: [Next] [New Search]